| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6123242 | Journal of Infection | 2014 | 9 Pages |
Abstract
HBsAg-positive patients are at significantly increased risk of adverse clinical outcomes after starting ART. Further studies are warranted to evaluate whether these risks remain now that tenofovir is becoming routinely available in Ghana.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Fred Stephen Sarfo, Adetayo Kasim, Richard Phillips, Anna Maria Geretti, David R. Chadwick,